| 11345904 |
Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof |
Jason Pinkstaff, Adam Shaywitz, Natalie Ciaccio |
2022-05-31 |
| 11229687 |
TPP-1 formulations and methods for treating CLN2 disease |
Thomas Lester, Augustus O. Okhamafe, Charles A. O'Neill |
2022-01-25 |
| 10758598 |
TPP-1 formulations and methods for treating CLN2 disease |
Thomas Lester, Augustus O. Okhamafe, Charles A. O'Neill |
2020-09-01 |
| 10279015 |
TPP-1 formulations and methods for treating CLN2 disease |
Thomas Lester, Augustus O. Okhamafe, Charles A. O'Neill |
2019-05-07 |
| 7829123 |
Process |
Goran Eric Sundholm, Mustafa Demirbüker |
2010-11-09 |
| 7108867 |
Process for preparing particles |
Goran Eric Sundholm, Mustafa Demirbüker |
2006-09-19 |
| 6475524 |
Composition of matter |
Mikael Bisrat, Håkan Nyqvist, Mustafa Demirbüker |
2002-11-05 |
| 6468994 |
Budesonide particles and pharmaceutical compositions containing them |
Mikael Bisrat |
2002-10-22 |
| 6461642 |
Crystallization using supercritical or subcritical fluids |
Mikael Bisrat, Håkan Nyqvist, Mustafa Demirbüker |
2002-10-08 |
| 6346523 |
Budesonide particles and pharmaceutical compositions containing them |
Mikael Bisrat |
2002-02-12 |